Despite the heavy disease burden posed by hepatitis B, around 90% of people living with
hepatitis B are not diagnosed globally. Many of the affected populations still have limited or …

Background Alanine aminotransferase (ALT) measurement is essential for evaluation of liver
disease. We validated a novel rapid point‐of‐care (POC) test for ALT1 against laboratory …

Background: International guidelines for hepatitis B infection (HBV) recommend initiating
antiviral treatment based on viral replication with inflammation or fibrosis. HBV viral loads …

Background Treatment eligibility and the accuracy of its simplified criteria have been poorly
documented in patients with chronic hepatitis B virus (HBV) infection worldwide, especially …

Background and aims Access to Hepatitis B virus (HBV) DNA testing to determine treatment
eligibility is limited in low-income countries. Therefore, this study aimed to assess and …

Background: Viral hepatitis continues to be of global public health importance, especially
hepatitis B and C. Hepatitis B and C account for most of the mortality and morbidity …

Background Global elimination of hepatitis B virus (HBV) requires expanded uptake of
antiviral therapy, potentially by simplifying testing algorithms, especially in resource-limited …

Globally, viral hepatitis is responsible for more annual deaths than human
immunodeficiency virus, tuberculosis, or malaria. The majority of hepatitisdeaths (~ 1 million …

In low-income countries with a high burden of hepatitis B and C viruses, it is important to
develop inexpensive but effective strategies to diagnose and treat hepatitis. The aim of this …